Agilent Technologies Inc (NYSE:A) insider Dominique Grau sold 8,902 shares of Agilent Technologies stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $74.00, for a total transaction of $658,748.00. Following the transaction, the insider now owns 103,387 shares in the company, valued at $7,650,638. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Agilent Technologies stock opened at $71.91 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29. Agilent Technologies Inc has a 12 month low of $60.42 and a 12 month high of $75.11. The firm has a market cap of $23.24 billion, a PE ratio of 26.13, a P/E/G ratio of 2.04 and a beta of 1.36.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 19th. The medical research company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.74 by $0.07. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The business had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the previous year, the company posted $0.67 EPS. Agilent Technologies’s revenue was up 8.8% on a year-over-year basis. As a group, equities analysts expect that Agilent Technologies Inc will post 3.04 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 23rd. Stockholders of record on Monday, December 31st will be issued a dividend of $0.164 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 annualized dividend and a dividend yield of 0.91%. The ex-dividend date is Friday, December 28th. Agilent Technologies’s payout ratio is currently 21.51%.
Several institutional investors have recently bought and sold shares of A. SRS Capital Advisors Inc. lifted its stake in shares of Agilent Technologies by 75.9% in the 2nd quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 773 shares during the last quarter. TRUE Private Wealth Advisors acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at $181,000. AMG National Trust Bank acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at $212,000. UMB Bank N A MO acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at $219,000. Finally, Lido Advisors LLC acquired a new stake in shares of Agilent Technologies in the 3rd quarter valued at $220,000.
Several equities analysts have weighed in on A shares. Morgan Stanley lifted their price objective on shares of Agilent Technologies from $86.00 to $89.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 20th. ValuEngine upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, November 2nd. Goldman Sachs Group reiterated a “buy” rating and set a $82.00 price objective (up from $77.00) on shares of Agilent Technologies in a research report on Tuesday, September 18th. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday, October 16th. Finally, Deutsche Bank lifted their price objective on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, August 15th. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $78.75.
COPYRIGHT VIOLATION WARNING: “Insider Selling: Agilent Technologies Inc (A) Insider Sells 8,902 Shares of Stock” was first reported by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://dakotafinancialnews.com/2018/12/07/insider-selling-agilent-technologies-inc-a-insider-sells-8902-shares-of-stock.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: The Role of a Fiduciary and Individual Investors
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.